• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Theorem partners with Emergo for regulatory consulting

Theorem partners with Emergo for regulatory consulting

July 9, 2013
CenterWatch Staff

CRO Theorem Clinical Research, based in King of Prussia, Penn., has formed a strategic partnership with Emergo Group to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community. 

“Emergo Group complements our own global strategic regulatory affairs and clinical trial capabilities,” said D. Lee Spurgin Jr., Ph.D., Theorem’s senior vice president and general manager of medical device and diagnostic development. “Working together we can provide more services and a bigger global footprint, so our strategic relationship helps us to be a one-stop provider for our clients.”

Emergo Group is a regulatory consultancy with more than 2,500 medical device and in vitro diagnostic device (IVD) clients and offers a range of compliance and market access services in 25 countries, including global regulatory strategy, device registration, quality management system compliance, in-country regulatory representation and distributor qualification.

With offices in more than 30 countries worldwide, Theorem Clinical Research specializes in the management of complex clinical trials for biopharmaceuticals, medical devices and drug-device combination products.

“The right strategic relationship strengthens both companies,” said Emergo Group president and CEO Rene van de Zande. “We believe the synergy we achieve with Theorem is a benefit to all concerned.”  

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing